mounjaro patent expiration tirzepatide patent expiration As Novo's expires, GLP-1 generics go global Mounjaro, Zepbound: Generic GLP-1 Drugs

Epigenetic regulation of aging: implications for interventions of aging and diseases

Tirzepatide is a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with obesity or overweight with weight-related comorbidities

Mann, MD, Professor of Medicine, Friedrich Alexander University of Erlangen-Nrnberg and Head of KfH Kidney Centre, Munich, Germany, will discuss the safety outcomes

A few decades of this, and diverticulosis was rampant

4:3 intermittent fasting follows the same principle as the 5:2 diet but includes one additional fasting day per week three restricted days rather than two potentially creating a larger weekly calorie deficit whilst still allowing four normal eating days

Those taking other glucose-lowering medicines should receive guidance on dosage adjustments to avoid low blood sugar episodes